Kathrin Jansen, PhD Senior Vice President & Head of Vaccine R&D Pfizer.BNT162b2 Vaccine Candidate Against COVID-19.December 10, 2020
[2]https://www.usatoday.com/story/news/health/2021/01/06/covid-vaccine-cdc-reports-severe-allergic-reactions-anaphylaxis/6564018002/